-
1
-
-
33845599085
-
15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience
-
Sylvester J.E., Grimm P.D., Blasko J.C., et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 67 (2007) 57-64
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 57-64
-
-
Sylvester, J.E.1
Grimm, P.D.2
Blasko, J.C.3
-
2
-
-
43049168349
-
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes
-
Cahlon O., Zelefsky M.J., Shippy A., et al. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 330-337
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 330-337
-
-
Cahlon, O.1
Zelefsky, M.J.2
Shippy, A.3
-
3
-
-
43049160704
-
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant
-
Eade T.N., Horwitz E.M., Ruth K., et al. A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys 71 (2008) 338-345
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 338-345
-
-
Eade, T.N.1
Horwitz, E.M.2
Ruth, K.3
-
4
-
-
72049103294
-
Comparison of 7-year outcomes between LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer. ASTRO Annual Scientific Meeting. Vol. 69. Los Angeles, CA
-
Zelefsky M., Yamada Y., Hunt M., et al. Comparison of 7-year outcomes between LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer. ASTRO Annual Scientific Meeting. Vol. 69. Los Angeles, CA. Int J Radiat Oncol Biol Phys (2007)
-
(2007)
Int J Radiat Oncol Biol Phys
-
-
Zelefsky, M.1
Yamada, Y.2
Hunt, M.3
-
5
-
-
62649113380
-
Evaluation of dosimetric parameters and disease response in 1006 consecutive patients treated with 125-Iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer
-
Morris W., Keyes M., Palma D., et al. Evaluation of dosimetric parameters and disease response in 1006 consecutive patients treated with 125-Iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 73 (2009) 1432-1438
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 1432-1438
-
-
Morris, W.1
Keyes, M.2
Palma, D.3
-
6
-
-
0036150169
-
Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes
-
Blasko J.C., Mate T., Sylvester J.E., et al. Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 12 (2002) 81-94
-
(2002)
Semin Radiat Oncol
, vol.12
, pp. 81-94
-
-
Blasko, J.C.1
Mate, T.2
Sylvester, J.E.3
-
7
-
-
4444318530
-
125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy
-
Keyes M., Pickles T., Agranovich A., et al. 125I reimplantation in patients with poor initial dosimetry after prostate brachytherapy. Int J Radiat Oncol Biol Phys 60 (2004) 40-50
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 40-50
-
-
Keyes, M.1
Pickles, T.2
Agranovich, A.3
-
8
-
-
24944526722
-
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
-
Lukka H., Hayter C., Julian J.A., et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 23 (2005) 6132-6138
-
(2005)
J Clin Oncol
, vol.23
, pp. 6132-6138
-
-
Lukka, H.1
Hayter, C.2
Julian, J.A.3
-
9
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 965-974
-
-
Roach III, M.1
Hanks, G.2
Thames Jr., H.3
-
10
-
-
33748563593
-
A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems
-
Williams S.G., Pickles T., Kestin L., et al. A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systems. Int J Radiat Oncol Biol Phys 65 (2006) 1494-1500
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1494-1500
-
-
Williams, S.G.1
Pickles, T.2
Kestin, L.3
-
11
-
-
17844374323
-
PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy
-
Bates A.T., Pickles T., and Paltiel C. PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 148-153
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 148-153
-
-
Bates, A.T.1
Pickles, T.2
Paltiel, C.3
-
12
-
-
61349085409
-
Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy. Sequential outcomes of 712 men
-
Keyes M., Miller S., Morovan V., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy. Sequential outcomes of 712 men. Int J Radiat Oncol Biol Phys 73 (2009) 1023-1032
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 1023-1032
-
-
Keyes, M.1
Miller, S.2
Morovan, V.3
-
13
-
-
72049095988
-
Timing of androgen deprivation therapy after radical radiotherapy failure: A survey of Canadian practitioners
-
S66-S66
-
Cheung P.C., Loblaw D.A., Pickles T., et al. Timing of androgen deprivation therapy after radical radiotherapy failure: A survey of Canadian practitioners. Radiother Oncol 80 (2006) S66-S66
-
(2006)
Radiother Oncol
, vol.80
-
-
Cheung, P.C.1
Loblaw, D.A.2
Pickles, T.3
-
14
-
-
63149196150
-
Population based study of biochemical and survival outcomes after permanent (125)I brachytherapy for low- and intermediate-risk prostate cancer
-
Morris W., Keyes M., Palma D., et al. Population based study of biochemical and survival outcomes after permanent (125)I brachytherapy for low- and intermediate-risk prostate cancer. Urology 73 (2009) 860-867
-
(2009)
Urology
, vol.73
, pp. 860-867
-
-
Morris, W.1
Keyes, M.2
Palma, D.3
-
15
-
-
2942534108
-
Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging
-
Pickett B., Ten Haken R.K., Kurhanewicz J., et al. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 59 (2004) 665-673
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 665-673
-
-
Pickett, B.1
Ten Haken, R.K.2
Kurhanewicz, J.3
-
16
-
-
0031024370
-
Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen
-
Crook J.M., Bahadur Y.A., Bociek R.G., et al. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen. Cancer 79 (1997) 328-336
-
(1997)
Cancer
, vol.79
, pp. 328-336
-
-
Crook, J.M.1
Bahadur, Y.A.2
Bociek, R.G.3
-
17
-
-
67349130809
-
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy
-
Stock R.G., Klein T.J., Cesaretti J.A., et al. Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 74 (2009) 753-758
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 753-758
-
-
Stock, R.G.1
Klein, T.J.2
Cesaretti, J.A.3
-
18
-
-
0036895121
-
Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer
-
D'Amico A.V., Cote K., Loffredo M., et al. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 20 (2002) 4567-4573
-
(2002)
J Clin Oncol
, vol.20
, pp. 4567-4573
-
-
D'Amico, A.V.1
Cote, K.2
Loffredo, M.3
-
19
-
-
43049153221
-
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time
-
discussion 2185-2186
-
Arlen P.M., Bianco F., Dahut W.L., et al. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol 179 (2008) 2181-2185 discussion 2185-2186
-
(2008)
J Urol
, vol.179
, pp. 2181-2185
-
-
Arlen, P.M.1
Bianco, F.2
Dahut, W.L.3
-
20
-
-
54049148613
-
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
-
Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 980-988
-
-
Al-Mamgani, A.1
van Putten, W.L.2
Heemsbergen, W.D.3
-
21
-
-
45449093563
-
Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
-
Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 1028-1033
-
-
Zelefsky, M.J.1
Yamada, Y.2
Fuks, Z.3
-
22
-
-
40349101662
-
Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate
-
Zietman A.L. Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate. JAMA 299 (2008) 898-899
-
(2008)
JAMA
, vol.299
, pp. 898-899
-
-
Zietman, A.L.1
-
23
-
-
34548481535
-
The Titanic and the iceberg: prostate proton therapy and health care economics
-
Zietman A.L. The Titanic and the iceberg: prostate proton therapy and health care economics. J Clin Oncol 25 (2007) 3565-3566
-
(2007)
J Clin Oncol
, vol.25
, pp. 3565-3566
-
-
Zietman, A.L.1
-
24
-
-
0036570337
-
Predictive factors of urinary retention following prostate brachytherapy
-
Bucci J., Morris W.J., Keyes M., et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 91-98
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 91-98
-
-
Bucci, J.1
Morris, W.J.2
Keyes, M.3
-
25
-
-
26944465026
-
Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?
-
Macdonald A.G., Keyes M., Kruk A., et al. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: Is dose to the penile bulb important?. Int J Radiat Oncol Biol Phys 63 (2005) 155-163
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.63
, pp. 155-163
-
-
Macdonald, A.G.1
Keyes, M.2
Kruk, A.3
-
26
-
-
31844446245
-
Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?
-
Keyes M., Schellenberg D., Moravan V., et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: The effect of learning curve?. Int J Radiat Oncol Biol Phys 64 (2006) 825-834
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 825-834
-
-
Keyes, M.1
Schellenberg, D.2
Moravan, V.3
-
27
-
-
10744230014
-
Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy
-
Liu M., Pickles T., Agranovich A., et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 59-67
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 59-67
-
-
Liu, M.1
Pickles, T.2
Agranovich, A.3
-
28
-
-
20044364932
-
Urinary incontinence in prostate cancer patients treated with external beam radiotherapy
-
Liu M., Pickles T., Berthelet E., et al. Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol 74 (2005) 197-201
-
(2005)
Radiother Oncol
, vol.74
, pp. 197-201
-
-
Liu, M.1
Pickles, T.2
Berthelet, E.3
-
30
-
-
58649103315
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial
-
Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial. Lancet 373 (2009) 301-308
-
(2009)
Lancet
, vol.373
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
|